SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!

MITUMITU

info@mitu.or.tz | +255 28 2500019 | Staff Mail
  • LOGIN
  • WHO WE ARE
    • History & Background
    • Mission & Values
    • Strategic Plan
    • Organization Structure
    • Our Team
  • WHERE WE ARE
    • Mwanza Medical Research Centre
    • Mwanza City
  • WHAT WE DO
    • Research Programme
    • Capacity Building
    • Research Facilities
  • PUBLICATIONS
  • NEWS & EVENTS
    • News & Events
    • Career
  • CONTACT US
Friday, 19 February 2021 / Published in News

A new study shows major benefits of increasing vaccination coverage against common infections in developing countries

vaccine-syringe

Results from this study highlight the importance of maintaining and increasing vaccine coverage to sustain gains made in reducing deaths related to infectious diseases in low-and middle-income countries.

Read full paper

  • Tweet
  • Share 0
  • Pocket
  • LinkedIn 0
  • Email

What you can read next

Two clinical trials launched in Europe to evaluate treatments for COVID-19
MITU is carrying out research with young men to understand intimate partner violence in Mwanza city.
Benefits of routine childhood vaccines far outweigh risks of additional COVID-19 transmission in Africa, modelling study suggests

Filter by Year

  • All Publications
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003

Recent Posts

  • Job Vacancy: Senior Finance Officer

  • MITU launches a new human papilloma virus (HPV) vaccine trial among boys in  Tanzania

  • Same habitus in new field? How mobile phone communication reproduces masculinities and gender inequality in intimate relationships in Mwanza, Tanzania.

  • Comparison of Immune Responses after One Dose of HPV Vaccine in a Dose-Reduction HPV Vaccine Trial in Adolescent Girls in Tanzania to the Costa Rica Vaccine and India HPV Vaccine Trials.

  • Immunogenicity and Safety Results Comparing Single Dose Human Papillomavirus Vaccine with Two or Three Doses in Tanzanian Girls – the DoRIS Randomised Trial.

Receive our latest news straight to your inbox

Join 220 other subscribers

CONTACT US

Contact us through the address below
Mwanza Intervention Trials Unit.

MITU, Isamilo Street,
P.O. Box11936,
Mwanza, Tanzania.

info@mitu.or.tz

+255 28 2500019

WHO WE ARE

  • History & Background
  • Mission & Values
  • Strategic Plan
  • Organization Structure
  • Our Team

WHAT WE DO

  • Research Programme
  • Capacity Building
  • Research Facilities

OUR SOCIAL

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

OUR PARTNERS

Tweets by mituorg
© 2021 MITU | All rights reserved.
TOP